Anticancer and anti-inflammatory activities of a standardized dichloromethane extract from Piper umbellatum L. leaves

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Iwamoto, Leilane Hespporte ^a,b   Vendramini Costa, Débora Barbosa ^b   Monteiro, Paula Araújo ^b   Ruiz, Ana Lúcia Tasca Gois ^a,b   De Oliveira Sousa, Ilza Maria ^b   Foglio, Mary Ann ^a,b   De Carvalho, João Ernesto ^a,b   Rodrigues, Rodney Alexandre Ferreira ^a,b  

^a School of Dentistry   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

4 NEROLIDYLCATECHOL; ANTIINFLAMMATORY AGENT; CATECHOL DERIVATIVE; DICHLOROMETHANE; DOXORUBICIN; INDOMETACIN; PHENOL DERIVATIVE; PIPER UMBELLATUM EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CARRAGEENAN-INDUCED PERITONITIS; CONTROLLED STUDY; DRUG ISOLATION; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PAW EDEMA; PERITONITIS; PLANT LEAF; PRIORITY JOURNAL; SOLID TUMOR; TOXICITY; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84923888298     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/948737     Document Type: Article

References (39)

1. D. J. Newman and G. M. Cragg, "Natural products as sources of new drugs over the 30 years from 1981 to 2010," Journal of Natural Products, vol. 75, no. 3, pp. 311-335, 2012.
2. Y. H. Wang, S. L. Morris-Natschke, J. Yang, H. M. Niu, C. L. Long, and K. H. Lee, "Anticancer principles from medicinal piper (hú jiao) plants," Journal of Traditional and Complementary Medicine, vol. 4, no. 1, pp. 8-16, 2014.
3. C. M. F. B. Roersch, "Piper umbellatum L.: a comparative crosscultural analysis of its medicinal uses and an ethnopharmacological evaluation," Journal of Ethnopharmacology, vol. 131, no. 3, pp. 522-537, 2010.
4. A. P. Lopes, B. S. Bagatela, P. C. P. Rosa et al., "Antioxidant and cytotoxic effects of crude extract, fractions and 4- nerolidylcathecol fromaerial parts of Pothomorphe umbellata L. (Piperaceae)," BioMed Research International, vol. 2013, Article ID 206581, 5 pages, 2013.
5. F. F. Perazzo,G.H. B. Souza,W. Lopes et al., "Anti-inflammatory and analgesic properties of water-ethanolic extract from Pothomorphe umbellata (Piperaceae) aerial parts," Journal of Ethnopharmacology, vol. 99, no. 2, pp. 215-220, 2005.
6. T. Isobe, A. Ohsaki, and K. Nagata, "Antibacterial constituents against Helicobacter pylori of Brazilian medicinal plant, Pariparoba," Yakugaku Zasshi, vol. 122, no. 4, pp. 291-294, 2002.
7. E. R. Rodrigues, N. G. P. Nogueira, G. J. Zocolo et al., "Pothomorphe umbellata: antifungal activity against strains of Trichophyton rubrum," Journal de Mycologie Medicale, vol. 22, no. 3, pp. 265-269, 2012.
8. J. L. Sacoman, K. M. Monteiro, A. Possenti, G. M. Figueira, M. A. Foglio, and J. E. Carvalho, "Cytotoxicity and antitumoral activity of dichloromethane extract and its fractions from Pothomorphe umbellata," Brazilian Journal of Medical and Biological Research, vol. 41, no. 5, pp. 411-415, 2008.
9. V. V. da Silva, C. D. Ropke, D. V. Miranda et al., "Photoprotective effect of Pothomorphe umbellata on UVB radiation-induced biomarkers involved in carcinogenesis of hairlessmouse epidermis," Cutaneous and Ocular Toxicology, vol. 28, no. 2, pp. 54-60, 2009.
10. L. O. Okunrobo, U. O. John, C. P. Fidelis, and O. Enosakhare, "Evaluation of anticonvulsant activity of aqueous extract and partitioned chloroform fraction of Piper umbellatum Linn (Piperaceae) leaves,"West African Journal of Pharmacy, vol. 24, pp. 43-48, 2013.
11. D. C. Baldoqui, V. D. S. Bolzani, M. Furlan, M. J. Kato, and M. O. M. Marques, "Flavones, lignans and terpene from Piper umbellata (piperaceae)," Química Nova, vol. 32, no. 5, pp. 1107-1109, 2009.
12. G. B. Longato, L. Y. Rizzo, I. M. de Oliveira Sousa et al., "In vitro and in vivo anticancer activity of extracts, fractions, and eupomatenoid-5 obtained from Piper regnellii leaves," Planta Medica, vol. 77, no. 13, pp. 1482-1488, 2011.
13. D. Hanahan and R. A. Weinberg, "Hallmarks of cancer: the next generation," Cell, vol. 144, no. 5, pp. 646-674, 2011.
14. S. I. Grivennikov, F. R. Greten, and M. Karin, "Immunity, inflammation, and cancer," Cell, vol. 140, no. 6, pp. 883-899, 2010.
15. J. Ferlay, I. Soerjomataram, M. Ervik et al., GLOBOCAN 2012 1.0. International Agency for Research on Cancer, 2013, http://globocan.iarc.fr/.
16. H. Li, X. Fan, and J. M. Houghton, "Tumor microenvironment: the role of the tumor stroma in cancer," Journal of Cellular Biochemistry, vol. 101, no. 4, pp. 805-815, 2007.
17. K. R. Rezende and S. B. D. M. Barros, "Quantification of 4- nerolidylcatechol from Pothomorphe umbellata (Piperaceae) in rats plasma samples by HPLC-UV," Revista Brasileira de Ciências Farmacêuticas, vol. 40, no. 3, pp. 373-380, 2004.
18. A. Monks, D. Scudiero, P. Skehan et al., "Feasibility of a highflux anticancer drug screen using a diverse panel of cultured human tumor cell lines," Journal of theNational Cancer Institute, vol. 83, no. 11, pp. 757-766, 1991.
19. R. H. Shoemaker, "The NCI60 human tumour cell line anticancer drug screen," Nature Reviews Cancer, vol. 6, no. 10, pp. 813-823, 2006.
20. A. J. Lapa, C. Souccar,M. T. R. Lima-Landman, M. A. S. Castro, and T. C. M. Lima, Métodos de Avaliação da Atividade Farmacol ógica de Plantas Medicinais, Setor de Produtos Naturais, Departamento de Farmacologia, UNIFESP/EPM, 5th edition, 2008.
21. S. C. Salgado Oloris, M. L. Z. Dagli, and J. L. Guerra, "Effect of β-carotene on the development of the solid Ehrlich tumor in mice," Life Sciences, vol. 71, no. 6, pp. 717-724, 2002.
22. G. M. Marchetti, K. A. Silva, A. N. Santos et al., "The anticancer activity of dichloromethane crude extract obtained from Calea pinnatifida," Journal of Experimental Pharmacology, vol. 4, pp. 157-162, 2012.
23. I. Posadas, M. Bucci, F. Roviezzo et al., "Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression," British Journal of Pharmacology, vol. 142, no. 2, pp. 331-338, 2004.
24. A. B. Awad, H. Williams, and C. S. Fink, "Phytosterols reduce in vitro metastatic ability ofMDA-MB-231 human breast cancer cells," Nutrition and Cancer, vol. 40, no. 2, pp. 157-164, 2001.
25. D.O. Moon,M.O. Kim, Y. H. Choi, and G. Y. Kim, "β-sitosterol induces G2/M arrest, endoreduplication, and apoptosis through the Bcl-2 and PI3K/Akt signaling pathways," Cancer Letters, vol. 264, no. 2, pp. 181-191, 2008.
26. C.A. Brohem, R. R. Massaro, M. Tiago et al., "Proteasome inhibition and ROS generation by 4-nerolidylcatechol induces melanoma cell death," Pigment Cell and Melanoma Research, vol. 25, no. 3, pp. 354-369, 2012.
27. Q. Mi, J. M. Pezzuto, N. R. Farnsworth, M. C. Wani, A. D. Kinghorn, and S. M. Swanson, "Use of the in vivo hollow fiber assay in natural products anticancer drug discovery," Journal of Natural Products, vol. 72, no. 3, pp. 573-580, 2009.
28. O. Trédan, C. M. Galmarini, K. Patel, and I. F. Tannock, "Drug resistance and the solid tumor microenvironment," Journal of the National Cancer Institute, vol. 99, no. 19, pp. 1441-1454, 2007.
29. J. A. Smith, H. Ngo, M. C. Martin, and J. K. Wolf, "An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines," Gynecologic Oncology, vol. 98, no. 1, pp. 141-145, 2005.
30. S. C. S. Oloris, M. L. Z. Dagli, and J. L. Guerra, "Effect of β-carotene on the development of the solid Ehrlich tumor in mice," Life Sciences, vol. 71, no. 6, pp. 717-724, 2002.
31. H. L. Stewart, "The cancer investigator," Cancer Research, vol. 19, pp. 804-818, 1959.
32. D. J. A. de Groot, E. G. E. de Vries, H. J. M. Groen, and S. de Jong, "Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic," Critical Reviews in Oncology/Hematology, vol. 61, no. 1, pp. 52-69, 2007.
33. H. Walczak, "TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, andcancer," Immunological Reviews, vol. 244, no. 1, pp. 9-28, 2011.
34. D. B. Vendramini-Costa and J. E. Carvalho, "Molecular link mechanisms between inflammation and cancer," Current Pharmaceutical Design, vol. 18, no. 26, pp. 3831-3852, 2012.
35. M. G. M. O. Henriques, P. M. R. Silva, M. A. Martins et al., "Mouse paw edema. A newmodel for inflammation?" Brazilian Journal of Medical and Biological Research, vol. 20, no. 2, pp. 243-249, 1987.
36. A. Navarro, B. De las Heras, and A. Villar, "Anti-inflammatory and immunomodulating properties of a sterol fraction from Sideritis foetens CLEM," Biological and Pharmaceutical Bulletin, vol. 24, no. 5, pp. 470-473, 2001.
37. V. Núñez, V. Castro, R. Murillo, L. A. Ponce-Soto, I. Merfort, and B. Lomonte, "Inhibitory effects of Piper umbellatum and Piper peltatum extracts towards myotoxic phospholipases A2 from Bothrops snake venoms: isolation of 4-nerolidylcatechol as active principle," Phytochemistry, vol. 66, no. 9, pp. 1017-1025, 2005.
38. D. B. Vendramini-Costa, I. B. D. D. Castro, A. L. T. G. Ruiz, C. Marquissolo, R. A. Pilli, and J. E. D. Carvalho, "Effect of goniothalamin on the development of Ehrlich solid tumor in mice," Bioorganic and Medicinal Chemistry, vol. 18, no. 18, pp. 6742-6747, 2010.
39. S. R. B. Damasceno, F. R. A. M. Oliveira, N. S. Carvalho et al., "Carvacryl acetate, a derivative of carvacrol, reduces nociceptive and inflammatory response in mice," Life Sciences, vol. 94, no. 1, pp. 58-66, 2014.